Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276703 · ClinicalTrials.gov registry record
Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 30
- Enrollment target
NCT02276703: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT02276703 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276703 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Pain in hospitalized patients has received increasing attention, however due to its subjective nature, it has defied objective, quantitative measurements. If a patient is able to communicate, pain may be assessed using standardized sentences, visual analog scales (VAS) or plain numeric scales. When a patient is unable to communicate, a method that would allow the caregiver to continuously monitor patients' pain and alert the provider that the patient may be in pain would be quite useful. The Pain Monitor uses a novel measurement technique of analyzing changes in skin conductance that can be used in patients who are unable to provide a subjective pain score. This study will compare the relationship between the measurements taken by the PainMonitor and pain scores given by communicative patients to evaluate the safety and efficacy of this monitor during planned, routine procedures.
Primary Outcome
Sensitivity and specificity with a confidence interval \> 80 % when skin conductance responses per sec are \> 0.13 and VAS is equal to or greater than 30 mm. This end point will be reached by 100 patients with at least 10 discrete measurements for each patient.
Interventions
- DEVICE Skin Conductance Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-06 |
What the finished NCT02276703 record still lists
NCT02276703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Skin Conductance Monitor is the first listed.
NCT02276703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02276703 about?
NCT02276703 is a clinical study titled "Comparison of the Skin Conductance Values and Patient Pain Scores During Minor Procedures in the ICU". Pain in hospitalized patients has received increasing attention, however due to its subjective nature, it has defied objective, quantitative measurements. If a patient is able to communicate, pain may be assessed using standardized sentences, visual analog scales (VAS) or plain numeric scales. When...
What is the current status of trial NCT02276703?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-10. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02276703?
The interventions under investigation include: Skin Conductance Monitor (DEVICE).
Who is sponsoring clinical trial NCT02276703?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia